An analysis of the mean of all time points demonstrated that the COVID-19 patient group showed elevated levels of ND1 mtDNA compared with those of the control group (controls: 65 (28–119) copies/μL; patients: 363 (167–987) copies/μL; p < 0.001; Figure 1A). The gene discussed is MT-ND1; the disease is COVID-19.